The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

Keep an eye on Alcon (ACL)

 Jun 03, 2008 01:24 PM UTC
Return Risk
+3.28% MID
Tracked Blogger
Symbol Sentiment Start Return Closed
ACL Positive 06/03/08 -6.70% --

Graphic_arrow1 Via BloggingStocks:  

Filed under: International markets, Newsletters, Stocks to Buy

"You may not have your eye on Alcon Inc. (NYSE: ACL), but if you wear contact lenses, suffer from dry eyes, worry about glaucoma, or even if you have hay-fever, you may have bought ACL products," notes global expert Frida Ghitis.


Here, the contributing advisor to Vivian Lewis' Global Investing, explains, "This Swiss eye drug giant has with its eyes on both the bottom line and the pipeline.


"As the world's largest eye care company, ALC has excellent management, stellar performance, promising demographics, and an intriguing ownership structure.


"Demographics bode well. Aging eyes need attention. Demand will rise for glaucoma medication, dry eye treatments, and other Alcon top sellers. As emerging markets grow their middle class, eye-care will be affordable by millions more people.

Continue reading Keep an eye on Alcon (ACL)

Permalink | Email this | Comments

<map name="google_ad_map_145-1213935"><area href="http://imageads.googleadservices.com/pagead/imgclick/145-1213935?pos=0" shape="rect" coords="1,2,367,28" /><area href="http://services.google.com/feedback/abg" shape="rect" coords="384,10,453,23" /></map>





 Graphic_website1 Read the rest of original post »



Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch